07:31 EST Moderna (MRNA) shares drop 19% after 2025 revenue guidance falls below estimates
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Moderna sees FY25 revenue $1.5B-$2.5B, consensus $2.94B
- Is There an Opportunity in Moderna Stock’s Volatility?
- Biotech Alert: Searches spiking for these stocks today
- Trump Trade: New administration to invest $20B to build data centers
- Wall Street’s Best and Worst Performers of 2025: Week 1